Table 3.
Experimental study measures, and results by payment group (n = 152 free, n = 151 copay)
| Measures | Fully Subsidized, Mean (SD) | Co-Payment, Mean (SD) | F (1, 299) for Payment Group | p Valuea |
|---|---|---|---|---|
| Follow-up intentions | ||||
| How likely are you to call your doctor in the next a few days to make an appointment to talk about all of the above? (1=Not likely; 7 = Very likely) |
4.39 (1.89) | 4.77 (1.84) | 3.88 | .050** |
| Test result perceptions | ||||
| How trustworthy are the test results? (1=Not at all; 7 = Very much) |
5.13 (1.10) | 5.41 (1.04) | 5.19 | .02** |
| How accurate are the test results? (1=Not at all; 7 = Very much) |
5.03 (1.04) | 5.27 (1.12) | 3.86 | .050** |
| How informative are the test results? (1=Not at all; 7 = Very much) |
5.59 (1.28) | 5.59 (1.21) | 0.004 | .95 |
| How high quality is this test? (1=Not at all; 7 = Very much) |
5.11 (1.15) | 5.37 (1.11) | 4.02 | .046** |
| Lifestyle change intention | ||||
| Omega-3 has been found to have many health benefits related to the conditions above. How likely are you to start taking (or continue to take) an Omega-3 supplement daily? (1=Not likely; 7 = Very likely) |
5.44 (1.57) | 5.52 (1.57) | .17 | .68 |
| General attitude towards test results | ||||
| How seriously do you take the test results? (1=Not at all; 7 = Very much) |
5.53 (1.26) | 5.68 (1.26) | .94 | .33 |
| How interested are you to learn more about your test results? (1=Not at all; 7 = Very much) |
5.90 (1.24) | 5.91 (1.19) | .04 | .85 |
| Cost perceptions | ||||
| How costly (money-wise) is this test to you? (1=Not at all; 7 = Very much) |
2.37 (1.98) | 2.96 (1.78) | 7.09 | .008*** |
| Is this test worth the cost (money-wise)? (1=Not at all; 7 = Very much) |
6.03 (1.40) | 5.78 (1.31) | 2.44 | .12 |
| How costly (effort-wise) is this test to you? (1=Not at all; 7 = Very much) |
2.98 (2.02) | 3.34 (2.07) | 2.08 | .15 |
| Is this test worth the cost (effort-wise)? (1=Not at all; 7 = Very much) |
6.01 (1.32) | 5.91 (1.30) | .30 | .58 |
ANCOVA, analysis of covariance.
aANCOVA with payment group as independent variable, gender, and age as covariates.
**Significant at the p = .05 level.
***Significant at the p = .01 level.